Integrated Core Strategies (US) LLC 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-31 4:23 pm Sale | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 4,192,865 4.000% | -1,556,150 (-27.07%) | Filing |
| 2024-03-25 4:36 pm Purchase | 2024-03-19 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,749,015 5.500% | 736,732 (+14.70%) | Filing |
| 2024-02-01 4:25 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,012,283 4.800% | -758,611 (-13.15%) | Filing |
| 2023-11-17 4:05 pm Purchase | 2023-11-08 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 5,770,894 5.600% | 5,770,894 (New Position) | Filing |